Notably, since we observed that both the S-II and S-III subgroups were associated with poor prognosis, we evaluated the expression of PRKDC (an independent prognostic molecule of melanoma (Fig. 2e)) among the three proteomic subtypes. The gene discussed is PRKDC; the disease is melanoma.